BeStock  
Stocks › EWTX

Edgewise Therapeutics EWTX

US equityMarket cap rank #2209Biotechnology
$40.30 −$1.10 (-2.66%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $40.30 0.00%
Open$41.55
Prev close$41.40
Day range$39.98 – $41.79
Volume1.63M
Market cap$4.38B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts8
Average target$55.83+38.5% vs. price
  • Buy 100%
Low $51.00Now $40.30Avg $55.83High $60.00

Recent rating changes

The last 20 actions on file set price targets from $41.00 to $60.00, averaging $55.24.

DateFirmRatingTarget
23 Sep 2026 Truist Financial BUY –
23 Sep 2026 Wedbush BUY $53.00
23 Sep 2026 Leerink Partners BUY –
23 Sep 2026 H.C. Wainwright BUY $57.00
22 Sep 2026 RBC Capital BUY $59.00
21 Sep 2026 H.C. Wainwright BUY $57.00
1 Sep 2026 RBC Capital BUY $59.00
27 Aug 2026 RBC Capital BUY $59.00
20 Aug 2026 J.P. Morgan BUY $60.00
19 Aug 2026 J.P. Morgan BUY $60.00
7 Aug 2026 Evercore BUY $55.00
6 Aug 2026 RBC Capital BUY $59.00
20 Jul 2026 Evercore BUY $55.00
9 Jul 2026 Oppenheimer BUY $51.00
6 Jul 2026 Guggenheim BUY $51.00
17 Jun 2026 Truist Financial BUY –
17 Jun 2026 Wedbush BUY $52.00
17 Jun 2026 Guggenheim BUY $41.00
17 Jun 2026 RBC Capital BUY $59.00
16 Jun 2026 Leerink Partners BUY $52.00

Discussion

No comments yet — be the first to weigh in on EWTX.

Leave a comment

Scroll to Top